Literature DB >> 16857328

Cognitive function in late versus early postmenopausal stage.

Sarah Elsabagh1, David E Hartley, Sandra E File.   

Abstract

OBJECTIVES: There are relatively few studies of cognitive performance in the first few postmenopausal years and insufficient data on whether there is differential decline in different cognitive abilities. The aim of the present analysis was to determine the nature of cognitive decline across a range of functions within a period of 5 years from early to late postmenopausal stage.
METHODS: In a cross-sectional study, 189 postmenopausal women, who had experienced a natural menopause, were not taking hormonal medication and had not done so in the previous 12 months, were divided according to their postmenopausal stage into early (stage +1, < or =5 years since the last menstrual period, aged 55.4+/-0.3 years, n=80), or late (stage +2, >5 years since the last menstrual period, aged 59.8+/-0.4 years, n=109) postmenopausal stages. Participants completed a comprehensive battery of tests measuring attention, episodic and semantic memory, planning and mental flexibility. Participants also completed self-ratings of mood, sleepiness and menopausal symptoms.
RESULTS: There were no differences between the groups in their performance in tests of attention, verbal fluency or memory. However, in the two tests of executive function (planning and mental flexibility) the women in the late postmenopausal stage performed significantly worse than the women in the early postmenopausal stage. These differences remained significant when effects of age and IQ were taken into account by analyses of covariance. There were no differences between the groups in their ratings of mood or of habitual sleepiness, or of feeling sleepy at the start of testing. However, by the end of testing the women in the late postmenopausal stage rated themselves as feeling sleepier than did the women in the early postmenopausal stage. The group differences in executive function remained significant when these differences in sleepiness were accounted for.
CONCLUSIONS: Although there were no differences in attention, verbal fluency and memory, executive function was significantly poorer in the late postmenopausal stage women, suggesting that this aspect of cognition deteriorates more rapidly than other functions. This change was independent of change in age, suggesting that hormonal changes between the early and late postmenopausal stages may be responsible.

Entities:  

Mesh:

Year:  2006        PMID: 16857328     DOI: 10.1016/j.maturitas.2006.06.007

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  9 in total

Review 1.  Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline.

Authors:  Karyn M Frick
Journal:  Behav Neurosci       Date:  2012-02       Impact factor: 1.912

2.  Hormonal environment affects cognition independent of age during the menopause transition.

Authors:  Alison Berent-Spillson; Carol C Persad; Tiffany Love; MaryFran Sowers; John F Randolph; Jon-Kar Zubieta; Yolanda R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 3.  Actions and interactions of estradiol and glucocorticoids in cognition and the brain: Implications for aging women.

Authors:  Alexandra Ycaza Herrera; Mara Mather
Journal:  Neurosci Biobehav Rev       Date:  2015-04-27       Impact factor: 8.989

4.  Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties.

Authors:  Sheila Shanmugan; James Loughead; Ravi Prakash Reddy Nanga; Mark Elliott; Hari Hariharan; Dina Appleby; Deborah Kim; Kosha Ruparel; Ravinder Reddy; Thomas E Brown; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

5.  Chronic Estradiol Administration During the Early Stage of Alzheimer's Disease Pathology Rescues Adult Hippocampal Neurogenesis and Ameliorates Cognitive Deficits in Aβ1-42 Mice.

Authors:  Jin-Yu Zheng; Ke-Shan Liang; Xian-Jun Wang; Xue-Ying Zhou; Jian Sun; Sheng-Nian Zhou
Journal:  Mol Neurobiol       Date:  2016-11-12       Impact factor: 5.590

Review 6.  Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials.

Authors:  Elizabeth Barrett-Connor; Gail A Laughlin
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

7.  Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women.

Authors:  Paul Merritt; Bethany Stangl; Elliot Hirshman; Joseph Verbalis
Journal:  Brain Res       Date:  2012-09-14       Impact factor: 3.252

Review 8.  The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease.

Authors:  Sajad Sahab-Negah; Vahid Hajali; Hamid Reza Moradi; Ali Gorji
Journal:  Cell Mol Neurobiol       Date:  2019-09-09       Impact factor: 5.046

9.  Overview of the Effect of Herbal Medicines and Isoflavones on the Treatment of Cognitive Function.

Authors:  Nasibeh Roozbeh; Reyhaneh Kashef; Masumeh Ghazanfarpour; Leila Kargarfard; Leili Darvish; Talat Khadivzadeh; Fatemeh Rajab Dizavandi; Maliheh Afiat
Journal:  J Menopausal Med       Date:  2018-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.